Latest filing published 16 Dec 2008 for RespireRx Pharmaceuticals Inc., €2,396.
Insider track record
No signal scores available.
Steven Andrew Johnson: trading record in brief
Steven Andrew Johnson discloses dealings in RespireRx Pharmaceuticals Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 30 May 2008 and the latest from 15 December 2008.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 16 December 2008: an option exercise of €2,396, in RespireRx Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Steven Andrew Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,750 shares@ US$0.375Common StockSEC:0001181431-08-067717:0
- 11,012 shares@ US$0.78Common StockSEC:0001181431-08-035918:0
2 of 2 declarations